Cite
HARVARD Citation
Geisen, U. et al. (2021). Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort. Annals of the rheumatic diseases. 80 (10), pp. 1306-1311. [Online].